Chimerism Directory Icon  - Kings Pathology Printer Icon - Kings Pathology

Haematology Overview / Directory

Test Icon  - Kings Pathology

Purpose of the test

The Chimerism investigation is carried out to monitor the engraftment of Bone Marrow (BM), Peripheral Blood (PB), CD3 T-cells, CD15 Granulocytes and CD19 B-Cells following haemopoietic stem cell transplant.

The microsatellite regions which the individual primer sets are designed to amplify, consist of repetitive sequences (short tandem repeats STRs) of DNA 3-7 base pairs in length. These STRs are well distributed throughout the human genome and are highly polymorphic. There are many advantages of STR typing. It is more tolerant of the use of degraded DNA templates than other typing methods because the amplification products are less than 500bp long. STR typing is also amenable to a variety of rapid DNA purification techniques, which are compatible with PCR but do not provide enough DNA of appropriate quality for Southern blot-based analyses.

Donor and Pre-transplant recipient samples must be obtained before the Post transplant sample can be analysed. The donor and recipient samples are run in conjunction with all post transplant specimens (BM, PB or fractionated cells) to illustrate the individual polymorphic alleles which distinguish the donor population from the recipient.

Analysis of chimerism is valuable in assessing patients response to transplantation. Observing a complete donor profile in the post transplant samples indicates a successful transplant. Chimeric profiles, (the presence of both donor and recipient allelic peaks) depending on the donor to recipient ratio (%), may indicate a less successful engraftment or progression to relapse.

Following analysis, donor and recipient profiles can be semi-quantified in the post transplant sample by obtaining the values for the areas underneath respective peaks and calculating the percentages of each. A value is obtained for each of the informative genes and the mean is calculated to give a more accurate indication of the recipient status. The 16 gene profiles for each patient are printed and handed to the consultant haematologist at least 24 hours before the weekly chimerism meeting, where the individual cases are discussed with the BMT co-ordination team.

notes Icon  - Kings Pathology

Sample Requirements

500µl BM and 5-10ml PB for fractionation.

Presence of heparin anticoagulant will inhibit PCR applications. Clotted samples are unsuitable for DNA analysis.

Samples must be clearly labelled with the patient's first name, surname, D.O.B, hospital number and the date the sample was taken.

Transport Icon  - Kings Pathology

Storage and Transport

Samples must be in EDTA and transported to the MRD Laboratory within 24 hours.

First class postage is adequate but samples must be shipped with packaging appropriate for UN 3373 samples following packing instruction 650. See link below for further details.

http://www.dft.gov.uk

Samples should be addressed to:

Central Specimen Reception,

Ground Floor, Bessemer Wing,

King's College Hospital,

Denmark Hill,

London SE5 9RS,

United Kingdom

Time Icon  - Kings Pathology

Turnaround Time

10 working days.

Time Icon  - Kings Pathology

Time Limit for Extra Tests

Dependent upon additional tests - please enquire

Notes Icon  - Kings Pathology

Factors affecting results or interpretation

Post-transplanted samples can only be assessed alongside a donor and pre-transplant DNA profile. These samples must be provided as a one-off prior to the sending of post-transplant material.

Price Icon  - Kings Pathology

Price

Please contact the laboratory for prices

(* Discounts available for significant workloads)

Contact Icon  - Kings Pathology

Contacts

Dr Nicholas Lea

T 020 7848 5821

E nlea@nhs.net

Dr Atiyeh Abdallah

T 020 7848 5821 / 5809

E a.abdallah@nhs.net

Range Icon  - Kings Pathology

References

Edwards, A. et al. (1991) DNA typing with trimeric and tetrameric tandem repeats;; polymorphic loci, detection systems and population genetics. In:The Second International Symposium on Human Identification 1991, Promega Corporation, 31 - 52.

Edwards, A. et al. (1991) DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am Journal Hum. Genetics. 49, 746 - 56

Warne, D. et al. (1991) Tetranucleotide repeat polymorphism at the human B-actin related pseudogene 2 detected using the polymerase chain reaction. Nucl Acids Res. 19, 6980

File Icon  - Kings Pathology Aldolase Assay

File Icon  - Kings Pathology Alpha thalassaemia

File Icon  - Kings Pathology Antenatal Screen

File Icon  - Kings Pathology Anti-XA Assay

File Icon  - Kings Pathology Beta thalassaemia

File Icon  - Kings Pathology Bethseda Inhibitor Assay

File Icon  - Kings Pathology C-Kit Mutation

File Icon  - Kings Pathology CD34 enumeration

File Icon  - Kings Pathology Chimerism

File Icon  - Kings Pathology Cytogenetics

File Icon  - Kings Pathology d-dimer Assay

File Icon  - Kings Pathology DNA analysis for Factor V Leiden (FVL) & Prothrombin gene mu

File Icon  - Kings Pathology Factor Assays: FV111, F1X, FX1, FX11, FV, F11,FV11,FX

File Icon  - Kings Pathology G6PD genotyping

File Icon  - Kings Pathology Gilberts Syndrome Testing

File Icon  - Kings Pathology Globin chain synthesis

File Icon  - Kings Pathology Glucose 6 Phosphate Dehydrogenase (G6PD) deficiency screen

File Icon  - Kings Pathology Glucose 6 Phosphate Dehydrogenase Assay

File Icon  - Kings Pathology Glucose Phosphate Isomerase (GPI) Assay

File Icon  - Kings Pathology Glutathione (GSH)

File Icon  - Kings Pathology Haemoglobin (Hb) variants

File Icon  - Kings Pathology Haemoglobin F % Analysis

File Icon  - Kings Pathology Haemoglobin H Body detection

File Icon  - Kings Pathology Haemoglobin S % Analysis

File Icon  - Kings Pathology Haemoglobin Variant Identification

File Icon  - Kings Pathology Hams Test

File Icon  - Kings Pathology Heat Stability Test

File Icon  - Kings Pathology Heinz Body Preparation

File Icon  - Kings Pathology Heparin Induced Thrombocytopenia

File Icon  - Kings Pathology Hexokinase Assay

File Icon  - Kings Pathology Immunophenotyping for haematological malignancies

File Icon  - Kings Pathology Kleihauer Test (in cases of raised HbF)

File Icon  - Kings Pathology Lupus Anticoagulant Screen

File Icon  - Kings Pathology Methaemoglobin Assay

File Icon  - Kings Pathology Methaemoglobin Reductase Assay

File Icon  - Kings Pathology Miscellaneous Red Cell Enzyme Assays

File Icon  - Kings Pathology Mutation Assay : ABL Kinase Domain

File Icon  - Kings Pathology Mutation Assay : FLT3

File Icon  - Kings Pathology Mutation Assay : JAK2 Mutation (V617F)

File Icon  - Kings Pathology Mutation Assay : N-ras 12 and 61

File Icon  - Kings Pathology Mutation Assay : NPM mutations

File Icon  - Kings Pathology Newborn Screening

File Icon  - Kings Pathology Osmotic Fragility Test

File Icon  - Kings Pathology Phospho Glycerate Kinase (PGK) assay

File Icon  - Kings Pathology Phosphofructokinase (PFK) assay

File Icon  - Kings Pathology Platelet Aggregation Study

File Icon  - Kings Pathology PNH Screen

File Icon  - Kings Pathology Pre Flight Thrombophilia Screen (DVT)

File Icon  - Kings Pathology Pre-Anaesthetic Sickle Screen

File Icon  - Kings Pathology Prenatal Diagnosis

File Icon  - Kings Pathology Protein C Activity

File Icon  - Kings Pathology Pyruvate Kinase Assay

File Icon  - Kings Pathology Raised Hb F analysis

File Icon  - Kings Pathology Sickle Cell and Thalassaemia Screen

File Icon  - Kings Pathology Thrombophilia Screen

File Icon  - Kings Pathology Translocation RQ-PCR Assays

File Icon  - Kings Pathology von Willebrand Disease Screen

Close Go to Tests page